Ampoule
Latest AstraZeneca AB Patents:
- Arginase inhibitors and methods of use thereof
- Spirocyclic compounds
- METHODS OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME
- Arginase inhibitors and methods of use thereof
- Methods of treating heart failure with reduced ejection fraction
Description
FIG. 1 is a perspective view of the ampoule;
FIG. 2 is a front view thereof;
FIG. 3 is a right side view thereof;
FIG. 4 a left side view thereof;
FIG. 5 is a rear view thereof;
FIG. 6 is a bottom view thereof; and,
FIG. 7 is a top view thereof.
Claims
The ornamental design for an ampoule, as shown and described.
Referenced Cited
Patent History
Patent number: D458366
Type: Grant
Filed: May 22, 2001
Date of Patent: Jun 4, 2002
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Anders Hellberg (Södertälje), Carin Widerström (Höllviken)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/145,192
Type: Grant
Filed: May 22, 2001
Date of Patent: Jun 4, 2002
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Anders Hellberg (Södertälje), Carin Widerström (Höllviken)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Fish & Richardson P.C.
Application Number: 29/145,192
Classifications
Current U.S. Class:
Resilient (e.g., Squeeze Bulb, Bellows, Etc.) (9) (D24/115)
International Classification: 2402;
International Classification: 2402;